TSPO ‐ PET in pre‐surgical evaluations: Correlation of neuroinflammation and SEEG epileptogenicity mapping in drug‐resistant focal epilepsy
Epilepsia · 2025-02 · 66 (2) · 430-443
DOI: 10.1111/epi.18182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, online erschienen am 16.12.2024. Verfasst von Jennifer Kilmer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire d'Imagerie Biomédicale Multimodale (BioMaps), Service Hospitalier Frédéric Joliot, Université Paris-Saclay, CEA, CNRS, Inserm, Orsay, Fra…. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Positron-Emission Tomography, Epilepsies, Partial, Receptors, GABA. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fondation française pour la Recherche sur l'Epilepsie.
Abstract (Originalsprache)
Objectives
Resective surgery in drug‐resistant focal epilepsy (DRFE) requires extensive evaluation to localize the epileptogenic zone (EZ). When non‐invasive phase 1 assessments (electroencephalography, EEG; magnetic resonance imaging, MRI; and 18 F‐Fluorodeoxyglucose–positron emission tomography, [ 18 F]FDG‐PET) are inconclusive for EZ localization, invasive investigations such as stereo‐EEG (SEEG) are necessary. Epileptogenicity maps (Ems) visualize the EZ using SEEG‐identified ictal high‐frequency oscillations (iHFOs). PET imaging with radioligands targeting the18‐kDa translocator protein (TSPO), a marker of glial activation, may aid EZ localization. This study investigates the correlation between TSPO‐PET imaging and SEEG iHFOs in DRFE to determine the utility of TSPO‐PET in pre‐surgical assessments, especially in complex or non‐lesional cases.
Methods
Patients with DRFE and inconclusive phase 1 assessments were recruited from Bicêtre Hospital (AP‐HP) for a prospective study (Eudract 2017–003381‐27). They underwent SEEG and [ 18 F]DPA‐714 (N,N‐diethyl‐2‐(2‐(4‐(2‐(fluoro‐ 18 F)ethoxy)phenyl)‐5,7‐dimethylpyrazolo[1,5‐a]pyrimidin‐3‐yl)acetamide) (TSPO radioligand) PET imaging. Statistical parametric mapping (SPM) techniques analyzed significant [ 18 F]DPA‐714‐PET uptake (TSPO‐map) and generated epileptogenicity maps (EM‐map). Correlation analyses at regional and voxel‐of‐interest (VOI) levels assessed the relationship between TSPO‐map and EM‐map.
Results
We were able to obtain and analyze both maps in 12 of 17 patients recruited. A significant positive correlation between EM‐map and TSPO‐map in focal epilepsies was found regionally ( r = .81, p < .00004) and at the VOI level ( r = .79, p < .00003). Temporal, insular, parietal, and occipital regions showed particularly strong correspondence. In frontal epilepsies, TSPO‐map was more focal than EM‐map, suggesting increased specificity for SEEG planning. This study also demonstrated the benefit of the TSPO‐map in identifying multiple foci in multifocal epilepsies, with or without lesions. Significance These findings suggest that neuroinflammation may be a molecular substrate of the EZ in non‐lesional focal epilepsy. Identifying the EZ inpatients with complex DRFE and inconclusive MRI/[ 18 F]FDG‐PET imaging is essential to improve resective surgery outcomes. Combining TSPO‐PET imaging with SEEG recordings may help bridge this gap.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratoire d'Imagerie Biomédicale Multimodale (BioMaps), Service Hospitalier Frédéric Joliot, Université Paris-Saclay, CEA, CNRS, Inserm, Orsay, France.
- Neurophysiology and Epileptology Department, Hôpital Bicêtre, Assistance Publique des Hôpitaux de Paris (AP-HP), Université Paris-Saclay, Orsay, France.
- Department of Neurosurgery, Hôpital Bicêtre, Assistance Publique des Hôpitaux de Paris (AP-HP), Université Paris-Saclay, Orsay, France.
- School of Medicine, Université Paris Saclay, Le Kremlin-Bicêtre, France.
ORCID-Profile: Viviane Bouilleret
Förderung
- Fondation française pour la Recherche sur l'Epilepsie
Zitieren
APA
Kilmer, J., Rodrigo, S., Petrescu, A. M., Aghakhani, N., Herbrecht, A., Leroy, C., Tournier, N., Bottlaender, M., Taussig, D., & Bouilleret, V. (2025). TSPO ‐ PET in pre‐surgical evaluations: Correlation of neuroinflammation and SEEG epileptogenicity mapping in drug‐resistant focal epilepsy. Epilepsia, 66(2), 430-443. https://doi.org/10.1111/epi.18182
Vancouver
Kilmer J, Rodrigo S, Petrescu AM, Aghakhani N, Herbrecht A, Leroy C, et al. TSPO ‐ PET in pre‐surgical evaluations: Correlation of neuroinflammation and SEEG epileptogenicity mapping in drug‐resistant focal epilepsy. Epilepsia. 2025;66(2):430-443. doi:10.1111/epi.18182
BibTeX
@article{Kilmer2025,
author = {Kilmer, Jennifer and Rodrigo, Sebatian and Petrescu, Ana-Maria and Aghakhani, Nozar and Herbrecht, Anne and Leroy, Claire and Tournier, Nicolas and Bottlaender, Michel and Taussig, Delphine and Bouilleret, Viviane},
title = {TSPO ‐ PET in pre‐surgical evaluations: Correlation of neuroinflammation and SEEG epileptogenicity mapping in drug‐resistant focal epilepsy},
journal = {Epilepsia},
year = {2025},
volume = {66},
number = {2},
pages = {430--443},
doi = {10.1111/epi.18182}
}
EUVIMED